Lutetium (177Lu) chloride Billev (previously Illuzyce) Unione Europea - olandese - EMA (European Medicines Agency)

lutetium (177lu) chloride billev (previously illuzyce)

billev pharma aps - lutetium (177lu) chloride - radionuclide-beeldvorming - therapeutische radiofarmaca - lutetium (177lu) chloride billev is a radiopharmaceutical precursor, and it is not intended for direct use in patients. it is to be used only for the radiolabelling of carrier molecules that have been specifically developed and authorised for radiolabelling with lutetium (177lu) chloride.

Thallium Chloride (201Tl) Cis Bio International 37 MBq/ml inj. opl. i.v. flac. Belgio - olandese - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

thallium chloride (201tl) cis bio international 37 mbq/ml inj. opl. i.v. flac.

cis bio international - thallium(tl-201)chloride 37 mbq/ml - oplossing voor injectie - 37 mbq/ml - thallium(tl-201)chloride 37 mbq/ml - thallium (201tl) chloride

Natriumchloride Viaflo 0.9 % w/v inf. opl. i.v. Belgio - olandese - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

natriumchloride viaflo 0.9 % w/v inf. opl. i.v.

baxter sa-nv - natriumchloride 9 g/1000 ml - oplossing voor infusie - other i.v. solution additives

Natriumchloride Viaflo 0.9 % w/v inf. opl. i.v. Belgio - olandese - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

natriumchloride viaflo 0.9 % w/v inf. opl. i.v.

baxter sa-nv - natriumchloride 9 g/1000 ml - oplossing voor infusie - other i.v. solution additives

Natriumchloride Viaflo 0.9 % w/v inf. opl. i.v. Belgio - olandese - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

natriumchloride viaflo 0.9 % w/v inf. opl. i.v.

baxter sa-nv - natriumchloride 9 g/1000 ml - oplossing voor infusie - other i.v. solution additives

Natriumchloride Viaflo 0.9 % w/v inf. opl. i.v. Belgio - olandese - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

natriumchloride viaflo 0.9 % w/v inf. opl. i.v.

baxter sa-nv - natriumchloride 9 g/1000 ml - oplossing voor infusie - other i.v. solution additives

Sitagliptin / Metformin hydrochloride Mylan Unione Europea - olandese - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride mylan

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, type 2 - geneesmiddelen die worden gebruikt bij diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , drievoudige combinatietherapie) als aanvulling op dieet en lichaamsbeweging bij patiënten die onvoldoende gecontroleerd op hun maximale getolereerde dosis van metformine en een enz.). sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Vildagliptin / Metformin hydrochloride Accord Unione Europea - olandese - EMA (European Medicines Agency)

vildagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, type 2 - geneesmiddelen die worden gebruikt bij diabetes - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 en 5. 1 voor de beschikbare gegevens over verschillende combinaties).

Kaliumchloride 0,15% + Glucose 5% Fresenius Kabi, oplossing voor infusie Paesi Bassi - olandese - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

kaliumchloride 0,15% + glucose 5% fresenius kabi, oplossing voor infusie

fresenius kabi nederland b.v. amersfoortseweg 10 e 3712 bc huis ter heide - glucose 1-water 55 mg/ml samenstelling overeenkomend met ; glucose 0-water 50 mg/ml ; kaliumchloride (e 508) 1,5 mg/ml ; samenstelling overeenkomend met chloride (cl-) 20 mmol/l ; kalium (k+) 20 mmol/l - oplossing voor infusie - natriumhydroxide (e 524) ; water voor injectie ; zoutzuur (e 507), - electrolytes with carbohydrates

Kaliumchloride 0,3% + Glucose 5% Fresenius Kabi, oplossing voor infusie Paesi Bassi - olandese - CBG-MEB (College ter Beoordeling van Geneesmiddelen)

kaliumchloride 0,3% + glucose 5% fresenius kabi, oplossing voor infusie

fresenius kabi nederland b.v. amersfoortseweg 10 e 3712 bc huis ter heide - glucose 1-water 55 mg/ml samenstelling overeenkomend met ; glucose 0-water 50 mg/ml ; kaliumchloride (e 508) 3 mg/ml ; samenstelling overeenkomend met chloride (cl-) 40 mmol/l ; kalium (k+) 40 mmol/l - oplossing voor infusie - natriumhydroxide (e 524) ; water voor injectie ; zoutzuur (e 507), - electrolytes with carbohydrates